Handeln

Ono Pharmaceutical Co Ltd ADR News


4,86 $		+1,46%	+0,07 $

In : 4,5451 € | 26.04.24 21:46:16 Nasdaq OTC Other

aktualisieren | Orderbuch | Mehr Kurse »

WKN: A2N6NC

ISIN: US6827361030

US-Symbol: OPHLY

Typ: Aktie

Ono Pharmaceutical Co Ltd ADR News

01.12.23 - PR Newswire

Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million

Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million PR Newswire

01.12.23 - PR Newswire

Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million

Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million PR Newswire

20.01.17 - dpa-AFX

Merck & Co gegen Bristol-Myers Squibb: Erst Zulassungsglück, dann Patentpech

Wechselbad der Gefühle bei den US-Pharmakonzernen Merck & Co und Bristol-Myers Squibb: Erst profitierte Merck von einem Rückzieher des Konkurrenten bei einer ...

30.04.14 - PR Newswire

OTC Markets Group Announces First Quarter 2014 Performance of OTCM ADR Index

OTC Markets Group Announces First Quarter 2014 Performance of OTCM ADR Index PR Newswire

23.04.13 - PR Newswire

AMRI and Ono Broaden SMARTSOURCING™ Collaboration

AMRI and Ono Broaden SMARTSOURCING™ Collaboration New Agreement Extends Drug Discovery and Development Collaboration Between the Companies PR Newswire

23.04.13 - PR Newswire

AMRI and Ono Broaden SMARTSOURCING™ Collaboration

AMRI and Ono Broaden SMARTSOURCING™ Collaboration PR Newswire

Newssuche

Videos

26.04.24 +6,31%

Technical Trading: Gold Long freitags

Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Biotech-Einhorn!

FDA Zulassung für das CBD-Wunder?!
weiterlesen»

Anzeige